Nabriva Therapeutics (NBRV) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends Nabriva Therapeutics (NASDAQ:NBRV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.63%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$61,130.00Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$1,444.32 Get NBRV Insider Trade Alerts Want to know when executives and insiders are buying or selling Nabriva Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NBRV Insider Buying and Selling by Quarter Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Nabriva Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/1/2022Charles A Rowland JrDirectorSell8,496$0.17$1,444.32 12/28/2021Theodore R SchroederCEOBuy100,000$0.57$57,000.00 12/27/2021J. Christopher NaftzgerGeneral CounselBuy7,000$0.59$4,130.00 (Data available from 1/1/2013 forward) NBRV Insider Trading Activity - Frequently Asked Questions Who is on Nabriva Therapeutics's Insider Roster? The list of insiders at Nabriva Therapeutics includes Charles A Rowland Jr, J. Christopher Naftzger, and Theodore R Schroeder. Learn more on insiders at NBRV. What percentage of Nabriva Therapeutics stock is owned by insiders? 1.63% of Nabriva Therapeutics stock is owned by insiders. Learn more on NBRV's insider holdings. Nabriva Therapeutics Key ExecutivesDr. Colin Broom M.D. (Age 67)Director Compensation: $40kMr. J. Christopher Naftzger BA (Age 56)Esq., J.D., Interim CEO, Gen. Counsel & Sec. Mr. Daniel Dolan (Age 46)Chief Financial Officer More Insider Trading Tools from MarketBeat Related Companies SCYNEXIS Insider Transactions Galectin Therapeutics Insider Transactions Inozyme Pharma Insider Transactions Actuate Therapeutics Insider Transactions Verastem Insider Transactions DiaMedica Therapeutics Insider Transactions Nkarta Insider Transactions scPharmaceuticals Insider Transactions Heron Therapeutics Insider Transactions Greenwich LifeSciences Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:NBRV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nabriva Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Nabriva Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBRV Stock Alerts